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Over the last 65 years, the Kasai hepatoportoenterostomy (KPE) and 
liver transplantation (LT) have dramatically improved the outcomes 
of children with biliary atresia (BA).[1,2] In developed settings, 
5‑year native‑liver survival rates of up to 60%, and overall 5‑year 
survival rates of up to 90%, are reported.[3,4] The majority of South 
African (SA) children with BA are treated at resource‑poor state 
hospitals where, if diagnosed before the onset of biliary cirrhosis, 
they undergo KPE. However, the transplant‑free survival rates are 
probably lower than the survival rates reported in developed settings; 
this may be related to social, medical and genetic factors such as 
delayed presentation, inconsistent implementation of management 
protocols and the suboptimal management of pre‑ and postoperative 
complications owing to resource constraints. A previous study in 
Soweto, SA, revealed that only 14% of patients with BA were jaundice 
free after KPE.[4] Only 3 of 16 patients in a study in Nigeria had KPE, 
and none of them survived beyond 2 years.[5] Unlike in the UK, where 
KPE is performed only by a select number of surgeons, to improve 
outcomes, in Johannesburg KPE is performed by all paediatric 
surgeons.[6‑8]
Patient‑related factors also impact on survival rates. These can 
be broadly separated into factors related to pathogenesis (e.g. 
BA with splenic malformation syndrome, and anatomy of the 
biliary remnant), and the degree of hepatic fibrosis at the time of 
the operation (influenced by age at time of KPE, high aspartate‑
aminotransferase‑to‑platelet ratio, histological fibrosis scores, and 
high portal vein pressures).[2,9,10]
The paediatric end‑stage liver disease (PELD) score can be used 
as a marker to predict the outcome of KPE.[11] This scoring system, 
which is more commonly used as a LT allocation tool, is a good 
predictor of outcome in BA.[12] After KPE, resolution of jaundice has 
been shown to be another reliable prognostic factor, and a recent 
multicentre study showed that resolution of jaundice by 3 months 
post KPE conferred better native‑liver survival, especially if it was 
associated with a normal serum albumin (>35 g/dL).[13,14] 
The current study describes the outcomes of KPE operations 
performed at two tertiary hospitals in Johannesburg, SA. The surgery 
was performed by consultant surgeons using an open approach, 
fashioning a portoenterostomy after wide dissection of the portal 
plate, with the jejunojejunostomy construction according to the 
preference of the operating surgeon. The routine is to administer 
perioperative antibiotics and steroids to all patients, with the addition 
of ursodeoxycholic acid when available. The steroid used in the 
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Background. Without timely surgical intervention, most children with biliary atresia (BA) are not expected to live beyond 2 years of age. 
The initial intervention, the Kasai hepatoportoenterostomy (KPE), aims to achieve biliary drainage. Liver transplantation (LT) is performed 
if jaundice fails to clear or when biliary cirrhosis occurs. In under‑resourced South African (SA) academic state hospitals, KPE procedures 
are the standard of care for the majority of children with BA, but LT is becoming more routinely available. 
Objectives. To describe the outcomes of children with BA undergoing KPE, and to identify presenting clinical, laboratory and histological 
features that were associated with a more favourable outcome.
Methods. All children with BA who underwent KPE between January 2009 and June 2012 at the Johannesburg academic‑hospital complex 
were included. Clinical and laboratory parameters, including paediatric end‑stage liver disease (PELD) score at the time of KPE, liver 
histology fibrosis score, clearance of jaundice at 6 months and 24‑month survival were determined.
Results. Of 70 children with BA diagnosed during the study period, 43 (61.4%) underwent KPE, but only 12 (27.9%) achieved early 
resolution of jaundice. By 24 months, 14 (32.6%) of 43 children undergoing KPE were alive with their native liver, and 2 (4.7%) other 
children underwent LT. PELD score <15 and early resolution of jaundice, but not age at surgery or histological fibrosis score, predicted a 
favourable outcome. 
Conclusion. Children with BA undergoing KPE in SA state hospitals have a poor prognosis. The PELD score at the time of KPE best predicts 
24‑month survival. 
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majority of cases is intravenous methylprednisone 20  mg per day, 
weaned by 2.5 mg daily. When an intravenous dose of 5 mg is reached, 
it is changed to oral prednisone 5 mg daily for 1 ‑ 3 weeks. All patients 
are referred to the dietetics department for ongoing nutritional care. 
Since the time of this study, LT has become more frequently available 
to public‑sector patients, and predictors of native‑liver survival will 
be useful in planning optimal timing of LT.
Objectives
The primary objective was to describe the outcomes of patients 
undergoing KPE in Johannesburg. The secondary objective was to 
identify potential prognostic factors at the time of KPE that predicted 
survival with a native liver at 24 months.
Methods
A retrospective analysis of all children who underwent KPE in 
a 30‑month period between January 2009 and June 2012 at two 
academic hospitals in Johannesburg was undertaken. Clinical, 
laboratory and histological parameters (date of birth, gender, age 
at surgery, serum albumin and total bilirubin (SBR) concentration, 
international normalised ratio (INR), weight and height, histology 
and outcome data) were obtained from clinical records and abstracted 
into an electronic database. PELD scores at the time of KPE (within 
72 hours before the procedure and prior to correction of clotting 
defects) were calculated as described.[12] SBR levels at 3 ‑ 6 months 
post‑KPE were also retrieved. 
Histological slides from liver biopsies taken at the time of surgery 
were retrieved and examined by a single pathologist who was blinded 
to the patient’s outcome. Liver fibrosis secondary to BA was graded as 
follows: mild fibrosis (grade I) was defined as fibrosis involving <50% 
of portal tracts, ranging from fibrous expansion of the portal tracts to 
bridging fibrosis; moderate (grade II) as bridging fibrosis involving 
>50% of portal tracts without nodular architecture; and severe (grade 
III) as bridging fibrosis with >50% of portal tracts involved with 
nodular architecture.[15] 
Outcomes recorded include early resolution of jaundice, defined 
as achieving bilirubin values <34 μmol/L (2 g/dL) by 6 months post 
surgery, and long‑term success, defined as survival with native liver at 
24 months of age. Death or LT were events that contributed to failure 
of survival with a native liver. Participants who were lost to follow‑up 
were censored at the time of their last visit. 
Data were entered into an Excel 2010 (Microsoft, USA) spreadsheet 
and analysed using Stata Intercooled version 11 (StataCorp, USA). 
Chi‑square tests, Wilcoxon rank tests, and Kaplan‑Meier survival 
curves with Cox proportional hazard tests were used to estimate 
odds ratios and 95% confidence intervals. Spearman’s correlation 
coefficients were calculated to detect correlations between prognostic 
factors.
Ethics permission was obtained from the University of the 
Witwatersrand (Wits)’s Human Research Ethics Committee (Medical) 
(ref. no. M120954).
Results
Seventy children presented with BA during the study period. Forty‑
three (61.4%) of them underwent KPE. Their general characteristics 
are shown in Table 1.The remaining 27 did not have KPE performed 
for the following reasons:
• One mother refused surgery for her child
• Four children underwent laparotomy but not KPE because of 
the presence of a strong clinical suspicion of cirrhosis (nodular 
appearance of the liver): three with the absence of a portal plate 
and one with vascular abnormalities 
• One child had situs ambiguus with inoperable complex cyanotic 
congenital heart disease
• Twenty‑one children presented late and had established biliary 
cirrhosis, and therefore were not referred for KPE.
The mean age of the children at the time of KPE was 64 days (range 
24 ‑ 121). The PELD score at the time of surgery could be calculated 
for 35, and for 25, biopsy slides were retrieved. Six (24%) of these were 
core biopsies, with the remainder being wedge biopsies. Only 2 biopsies 
were graded as showing severe or grade III fibrosis (Table 1).  Of the 
43 children undergoing KPE, 12 (27.9%) achieved early resolution 
of jaundice, while 6 (14.0%) patients were already lost to follow‑up 
by 6 months, and 7 (16.3%) had died. The 7 early deaths included 1 
child with postoperative complications and nosocomial pneumonia, 1 
with upper gastrointestinal bleeding and suspected sepsis, 1 with HIV 
World Health Organization stage‑IV infection and chronic diarrhoea, 
and 1 with septicaemia. The cause of death for the other 3 was 
unknown. By 24 months post KPE, 14 (32.6%) were alive with their 
native liver, 2 (4.7%) had been transplanted, a further 4 (9.3%) had died 
and 9 (20.9%) others were lost to follow‑up (Fig. 1). This added up to 
a total of 11 (25.6%) deaths, and 16 (37.2%) children lost to follow‑up 
by 24 months of age. 
Table 1. Demographic characteristics of children with 
biliary atresia undergoing Kasai hepatoportoenterostomy in 
Johannesburg, South Africa
Characteristic* Median (IQR)†
Age (days), range‡ (N=43) 64 (46 ‑ 83)
Gender (N=43), n (%)
Female
Male 
30 (70)
13 (30)
HIV‑positive, (N=32), n (%) 1 (3)
Weight‑for‑age z‑score (N=33) –2.42 (–3 ‑ –1.2)
Length‑for‑age z‑score (N=32) –2.04 (–2.92 ‑ –0.57)
Weight‑for‑length z‑score (N=31) –0.63 (–1.93 ‑ 0.19)
Total bilirubin (µmol/L) (N=38) 195 (153 ‑ 244)
PELD score (N=38) 11 (8 ‑ 16)
Histological score (N=25), n (%)
Mild 
Moderate 
Severe 
14 (56)
9 (36)
2 (8)
IQR = interquartile range.
*Missing observations varied between variables.
†Unless otherwise specified. 
‡Range (days) = 24 ‑ 121.
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Fig. 1. Study flow diagram. (BA = biliary atresia; KPE = Kasai 
hepatoportoenterostomy.)
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Outcomes
There was poor correlation between age 
and PELD score, age and degree of fibrosis, 
and PELD score and degree of fibrosis 
(Spearman’s correlation coefficients 0.23, 
0.03 and 0.07, respectively; not significant). 
Age and histological fibrosis score were not 
significant predictors of early success. A 
PELD score <15 was a good predictor of 
resolution of jaundice at 6 months post KPE 
(likelihood ratio (LR): 6, p=0.024; Table 2).
Survival analysis revealed that a higher 
preoperative PELD score predicted worse 
native‑liver survival (p=0.013). Surgery after 
60 days of age (p=0.79) or higher histological 
fibrosis score (p=0.45) did not predict worse 
native‑liver survival. Achieving a total SBR 
below 34 µmol/L (2 g/dL) within 6 months 
after KPE predicted transplant‑free survival 
(p=0.0001) (Fig. 2, Table 3).
Discussion
In this resource‑poor setting, children with 
BA present late, with more than a third not 
able to receive KPE. Furthermore, of those 
who undergo KPE, the results are not as 
favourable as compared with outcomes in 
well‑resourced settings. A large percentage 
of patients defaulted on follow‑up post KPE. 
There was no other paediatric hepatology 
service in Johannesburg at the time, and it 
seems likely that most of these children did 
not survive beyond 24 months of age. To the 
best of our knowledge, none of the children 
in the group that did not have KPE or those 
who defaulted on follow‑up received a LT, 
giving an overall 2‑year survival rate of 21%, 
or 19% with native liver. The present study is 
one of the first to describe the outcomes seen 
in children with BA, some of whom undergo 
KPE, in a low‑ or middle‑income country 
setting. This information is likely to be 
useful when clinicians discuss the prognosis 
of children with BA with their parents. 
Furthermore, in low‑resourced settings, the 
effects of future therapeutic interventions in 
children with BA can be measured against 
the baseline that we have described. 
The survival rates are poor when 
compared with outcomes reported in 
developed‑country settings.[3,16] This is 
relevant because the incidence of BA in black 
SA infants may be among the highest of the 
world: in 1998, preliminary data in the same 
setting estimated the local incidence to be 
between 1 in 2 500 and 1 in 8 000 live births.[4] 
Elsewhere, incidences have been described 
ranging from 1 in 5  000 in Taiwan to 1 in 
20 000 in European populations.[9] 
Healthcare in SA is highly inequitable. In 
2014, 84% of the population did not have 
private medical insurance and accessed care 
in the state health sector, where 30% of the 
country’s doctors are employed.[17] The state 
sector’s annual per capita expenditure on 
health is USD40, compared with USD1 400 
in the private sector. As a consequence, 
interventions such as LT are frequently 
inaccessible to the majority of patients in 
need, as was reflected in this study. 
In order to improve outcomes for children 
with BA, three areas need to be addressed:
(i) timeous diagnosis and referral 
 (ii) optimal medical and surgical 
interventions by an expert team
 (iii) close monitoring and follow‑up with 
early identification of those who require LT.
Age at the time of surgery is widely accepted 
as having an influence on the outcome and 
success rate of achieving bile drainage and 
native‑liver survival, although the optimal 
timing is disputed.[8] The average age of this 
sample was 64 days, which is comparable with 
several first‑world settings.[16,18,19] However, 
the age of presentation would increase if 
those children who did not undergo KPE 
were included in the analysis. 
Table 2. Predictors of early success (6 months post KPE)
Factor
Early success 
(n=12)
Jaundice not cleared/death 
(n=25) Loss to follow-up (n=6) p-value *†
Age (days), median (IQR)
Age = <60 days, n/N (%)
57.5 (45 ‑ 89) 
6/12 (50)
66 (46 ‑ 75)
11/25 (44)
66 (37 ‑ 78)
2/6 (33)
0.88
0.73
PELD score, median (IQR)
PELD score <15, n/N (%)
10 (5 ‑ 12)
11/12 (92)
12 (10 ‑ 18)
11/21 (52)
9 (8 ‑ 10)
2/2 (100)
0.06
0.02‡
Histology fibrosis score
Mild, n/N (%)   
Moderate, n/N (%)
Severe, n/N, (%)
6/9 (67)
2/9 (22)
1/9 (11)
8/16 (50)
7/16 (44)
1/16 (6)
0
0
0 0.46
*Wilcoxon rank sum and likelihood ratio with Fisher’s exact tests used where applicable.
†Comparison between early success v. failure (jaundice not cleared or death) group.
‡p<0.05.
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Fig. 2. Kaplan-Meier survival curves by paediatric end-stage liver disease (PELD) score, histological 
fibrosis score, age at the time of Kasai hepatoportoenterostomy (KPE), and resolution of jaundice by 
3 months post KPE. (SBR = total serum bilirubin.)
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As has been noted before, there are no reliable prognostic markers 
predicting the success of KPE for BA. This is in part due to the 
heterogeneity of the disorder, with different aetiological pathways 
leading to the same end pathology.[20] The lack of association between 
age of presentation and histological score in this study was surprising. 
However, older children with established cirrhosis were excluded 
from surgical intervention, and the histological score used may not be 
sensitive enough to be used as a predictor of outcome in our setting. 
While the PELD score was a better predictor than young age and 
histological score, two children with a score >15 did survive to 24 
months with their native liver. We would therefore not recommend 
avoiding KPE based on this result, particularly given the scarcity of 
LT options in this setting. Nevertheless, offering KPE to children who 
present late with established cirrhosis and features of chronic liver 
failure is unlikely to result in a successful outcome. These children 
should be referred primarily for an evaluation by the LT team.
Achieving adequate biliary drainage and low SBR by 6 months post 
KPE was highly predictive of native‑liver survival to age two, and 
therefore these children should be followed‑up closely and monitored 
for complications.
Optimising outcomes in BA starts with early diagnosis and referral. 
Introduction of a stool‑colour card has been shown to be successful, 
and would help to raise awareness of the disease.[19] However, early 
identification alone will not necessarily result in improved outcomes, 
as this study has shown. 
Once the diagnosis has been made, it is beneficial to have a 
centralised model of care for these patients, with a few specialised 
surgeons performing the KPE in a few institutions.[16] Several peri‑ 
and postoperative multidisciplinary interventions have also been 
used to improve outcomes of the surgery.[7] Once again, centralisation 
of the management of this condition should improve adherence 
to these protocols, and therefore improve outcomes. The authors 
therefore recommend centralisation of care for children with BA, 
with all KPE operations being performed at selected centres by a team 
of experienced surgeons. After discharge, all these children require 
thorough follow‑up and monitoring, early detection of complications 
and appropriate nutritional support.
The definitive surgical link in the chain of managing children 
with BA is LT. SA currently has two paediatric LT services: one at 
the Red Cross War Memorial Children’s Hospital in Cape Town, 
and the other at the Wits Donald Gordon Medical Centre in 
Johannesburg. The latter has the expertise to perform living‑donor 
LTs, which assists greatly in light of the shortage of deceased‑
donor organs that exists locally and worldwide.[21,22] Increasingly, 
children in the state sector are gaining access to this therapeutic 
option, albeit on a limited basis. Factors that have contributed to 
this low rate of transplantation include poor social circumstances 
and lack of accessible transport, delays in diagnosis, work‑up 
and referral to the transplant centre, and limited remuneration 
and support from the National Department of Health (NDoH) 
for the LT programme, including post‑transplantation medical 
and supportive care. For children with BA who present to state 
facilities, support from the NDoH for a LT programme is vital to 
improving outcomes. 
Recognised study limitations include a small sample size, difficulty in 
obtaining clinical information, including the anatomical classification 
of the biliary tree, other malformations such as splenic malformations 
or dextrocardia, loss to follow‑up, and lack of details regarding 
the direct cause of death in those who died. Only 25 subjects’ liver 
biopsies could be retrieved and reviewed. Detailed clinical information 
about the patients’ medical management and healthcare professionals’ 
adherence to treatment guidelines is not known, but the study aims to 
describe outcomes in resource‑poor settings.
Conclusion
BA continues to carry a poor prognosis in many developing countries. 
Despite this, good outcomes are achievable, and efforts should be ramped 
up to promote awareness, increasing the chances of early diagnosis. 
Referral to a centre with KPE expertise is strongly recommended, with 
close follow‑up by a multidisciplinary team thereafter. 
As BA is the most common indication for paediatric LT in 
SA, successful KPE will have a positive impact on the transplant 
programme, and hopefully result in fewer young children requiring 
transplants. Nevertheless, equal access for indigent patients to the LT 
programme must be addressed urgently, and improved buy‑in from 
the NDoH is critical.
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Table 3. Outcomes at 24 months in children with BA undergoing KPE
Factor
Native-liver 
survival,
N=14
Death,
N=11
Liver transplant,
N=2
Loss to follow-up,
N=16 p-value *†
Age in days when KPE performed, median (IQR)
Age <60 days n/N, (%)
57.5 (49 ‑ 88)
7/14 (50)
69 (38 ‑ 101) 
5/11 (45)
49.5 (24 ‑ 75)
1/2 (50)
65 (49.5 ‑ 76.5)
6/16 (38)
0.75
0.84
PELD score, median (IQR)
PELD score <15, n/N (%)   
9.5 (3 ‑12)
12/14 (86)
16 (9 ‑ 18)
5/11 (45)
11.5 (11 ‑ 12) 
2/2 (100)
11.5 (10 ‑ 18)
5/8 (63)
0.032‡ 
0.066
Histology fibrosis score
Mild, n/N (%)
Moderate, n/N (%)
Severe, n/N (%)
6/10 (60)
2/10 (20)
2/10 (20)
6/9 (67)
3/9 (33)
0/9 (0)
0/1 (0)
1/1 (100)
0/1 (0)
2/5 (40)
3/5 (60)
0/5 (0) 0.50
Early success (SBR <34 µmol/L within 6 months), 
n/N (%)   11/14 (79) 0/11 (0) 0/2 (0) 1/10 (10) <0.001
BA = biliary atresia; KPE = Kasai hepatoportoenterostomy; IQR = interquartile range; SBR = total serum bilirubin.
*Comparison between native‑liver survivor group versus patients who died or received a liver transplant. 
†Wilcoxon rank sum and likelihood ratio tests used.
‡p<0.05.
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